Cancer cells often have altered metabolic pathways to sustain their rapid growth and proliferation. Mutations or alterations in enzymes involved in nucleotide metabolism, like HPRT, can contribute to the uncontrolled cell growth characteristic of cancer. In some cancers, HPRT activity is dysregulated, leading to an imbalance in nucleotide pools that can result in genomic instability and increased mutation rates.
